GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study

Circulation: Heart Failure

Volumn 9, Issue 3, 2016, Pages

  Sheppard, Richard ^a   Hsich, Eileen ^b   Damp, Julie ^c   Elkayam, Uri ^d   Kealey, Angela ^e   Ramani, Gautam ^f   Zucker, Mark ^g   Alexis, Jeffrey D ^h   Horne, Benjamin D ⁱ   Hanley Yanez, Karen ^j   Pisarcik, Jessica ^j   Halder, Indrani ^j   Fett, James D ^j   McNamara, Dennis M ^j  

^a MCGILL UNIVERSITY   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF MARYLAND   (United States)

^g Cardiac Catheterization Laboratory   (United States)

^h UNIVERSITY OF ROCHESTER   (United States)

ⁱ INTERMOUNTAIN MEDICAL CENTER   (United States)

^j UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

cardiomyopathy; heart failure; peripartum period; polymorphism genetics; pregnancy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; G-PROTEIN BETA3 SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GNB3 GENE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PERIPARTUM CARDIOMYOPATHY; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RACE DIFFERENCE; AFRICAN AMERICAN; CANADA; CARDIOMYOPATHIES; CLINICAL TRIAL; CONVALESCENCE; DISEASE FREE SURVIVAL; ENZYMOLOGY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTECTION; RISK FACTOR; TIME FACTOR; UNITED STATES; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; CANADA; CARDIOMYOPATHIES; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; PERIPARTUM PERIOD; PHENOTYPE; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREVALENCE; PROTECTIVE FACTORS; RECOVERY OF FUNCTION; RISK FACTORS; STROKE VOLUME; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84962539188     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002683     Document Type: Article

References (28)

1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ, Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010 12 767 778. doi: 10.1093/eurjhf/hfq120
2. Elkayam U., Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011 58 659 670. doi: 10.1016/j.jacc.2011.03.047
3. Capriola M., Peripartum cardiomyopathy: a review. Int J Womens Health 2013 5 1 8
4. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL., African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 2010 55 654 659. doi: 10.1016/j.jacc.2009.09.043
5. Moser M, Brown CM, Rose CH, Garovic VD., Hypertension in pregnancy: is it time for a new approach to treatment? J Hypertens 2012 30 1092 1100. doi: 10.1097/HJH.0b013e3283536319
6. Cruz MO, Briller J, Hibbard JU., Update on peripartum cardiomyopathy. Obstet Gynecol Clin North Am 2010 37 283 303. doi: 10.1016/j.ogc.2010.02.003
7. Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB., Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002 23 301 324. doi: 10.1385/CRIAI:23:3:301
8. Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R., High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005 193 363 365. doi: 10.1016/j.ajog.2005.01.022
9. Lamparter S, Pankuweit S, Maisch B., Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 2007 118 14 20. doi: 10.1016/j.ijcard.2006.04.090
10. Goland S, Modi K, Hatamizadeh P, Elkayam U., Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail 2013 19 214 218. doi: 10.1016/j.cardfail.2013.03.004
11. McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J, Markham DW, Marek J, Gorcsan J III, Wu WC, Lin Y, Halder I, Pisarcik J, Cooper LT, Fett JD, IPAC Investigators Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015 66 905 914. doi: 10.1016/j.jacc.2015.06.1309
12. Meirhaeghe A, Bauters C, Helbecque N, Hamon M, McFadden E, Lablanche JM, Bertrand M, Amouyel P., The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J 2001 22 845 848. doi: 10.1053/euhj.2000.2400
13. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B., Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998 18 45 48. doi: 10.1038/ng0198-45
14. Siffert W., G-protein b3 subunit 825T allele and hypertension. Curr Hypertens Rep 2003 5 47 53
15. Schunkert H, Hense HW, Döring A, Riegger GA, Siffert W., Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998 32 510 513
16. Schmitz B, De Maria R, Gatsios D, Chrysanthakopoulou T, Landolina M, Gasparini M, Campolo J, Parolini M, Sanzo A, Galimberti P, Bianchi M, Lenders M, Brand E, Parodi O, Lunati M, Brand SM., Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapy. Circ Cardiovasc Genet 2014 7 760 770. doi: 10.1161/CIRCGENETICS.113.000384
17. Siffert W, Forster P, Jöckel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns A, Epplen JT, Fridey J, Freedman BI, Müller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D., Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999 10 1921 1930
18. McNamara DM, Taylor AL, Tam SW, Worcel M, Yancy CW, Hanley-Yanez K, Cohn JN, Feldman AM., G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT. JACC Heart Fail 2014 2 551 557. doi: 10.1016/j.jchf.2014.04.016
19. Van Tintelen JP, Pieper PG, Van Spaendonck-Zwarts KY, Van Den Berg MP., Pregnancy, cardiomyopathies, and genetics. Cardiovasc Res 2014 101 571 578. doi: 10.1093/cvr/cvu014
20. Cemin R, Janardhanan R, Donazzan L, Daves M., Peripartum cardiomyopathy: moving towards a more central role of genetics. Curr Cardiol Rev 2013 9 179 184
21. Rosskopf D, Manthey I, Siffert W., Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics 2002 12 209 220
22. Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, Siffert W., G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res 1999 85 965 969
23. McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Taylor AL, Cohn JN, Feldman AM, Worcel M., Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. J Am Coll Cardiol 2006 48 1277 1282. doi: 10.1016/j.jacc.2006.07.030
24. McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Venkitachalam L, Ofili E, Yancy C, Feldman AM, Ghali JK, Taylor AL, Cohn JN, Worcel M., Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. J Card Fail 2009 15 191 198. doi: 10.1016/j.cardfail.2008.10.028
25. Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hill JA, Aranda JM, Yarandi HN, Johnson JA., Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. Pharmacogenet Genomics 2005 15 227 234
26. Chemello D, Rohde LE, Santos KG, Silvello D, Goldraich L, Pimentel M, Rosa PR, Zimerman L, Clausell N., Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure. Europace 2010 12 686 691. doi: 10.1093/europace/euq040
27. Kurnik D, Friedman EA, Muszkat M, Sofowora GG, Xie HG, Dupont WD, Wood AJ, Stein CM., Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses. Pharmacogenet Genomics 2008 18 743 750. doi: 10.1097/FPC.0b013e3282fee5a1
28. Faruque MU, Millis RM, Dunston GM, Kwagyan J, Bond V Jr, Rotimi CN, Davis T, Christie R, Campbell AL., Association of GNB3 C825T polymorphism with peak oxygen consumption. Int J Sports Med 2009 30 315 319. doi: 10.1055/s-0029-1202259